I. Lacroix et al., Microbial models of drug metabolism: Microbial transformations of Trimegestone (R) (RU27987), a 3-keto-Delta(4,9(10))-19-norsteroid drug, BIO MED CH, 7(11), 1999, pp. 2329-2341
Screening microorganisms for the biotransformation of the 3-keto-Delta(4.9(
10))-19-norsteroid RU27987 (Trimegestone(R)) resulted in the isolation of n
ine identified metabolites, some of them being selectively produced by diff
erent strains. Eight metabolites were found to be hydroxylated on various p
ositions of the rings, and one was additionally epoxidized. These microbial
metabolites could be used as chromatographic standards and two of them wer
e found identical to the unknown major human metabolites, Moreover, most mi
crobial metabolites were produced in sufficient amounts to be tested for th
eir biological activities. All these features demonstrate the usefulness an
d versatility of microbial biotransformation systems as a tool for early id
entification and convenient production of potentially active mammalian and
non-mammalian metabolites. (C) 1999 Elsevier Science Ltd. All rights reserv
ed.